StockData
Humana Inc logo

Humana Inc

HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 9/3040% above fair value
$410.41−4.09 (-0.99%)

Close on Nov 2, 2026Market cap $49.28BP/E 38.7Yield 0.86%

Humana CenterWell Non-GAAP Add-Back: Segment D&A Expense by Quarter

CenterWell Non-GAAP Add-Back: Segment D&A Expense ($M) ($M)

Humana CenterWell Non-GAAP Add-Back: Segment D&A Expense: $48M in Q2 2026, down 20.0% from a year earlier.

Latest, Q2 2026
48
Period ended Jun 30, 2026
Change on a year earlier
-20.0%
60 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below

Where the Q2 2026 figure comes from

“|| Depreciation and amortization expense | 48 | 60 | 97 | 119”

Source: HUM Form 8-K Statistical Supplement (2026-07-29) ↗

Reported in HUM SEC Filings (8-K Statistical Supplement / 10-K / DEF 14A).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Humana CenterWell Non-GAAP Add-Back: Segment D&A Expense ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Humana SEC filings and investor materials. https://stockdatahq.com/stocks/hum/kpis/nongaap-cw-da

See every metric in the Humana KPI table. Data updated Nov 2, 2026.